GR3024480T3 - Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus - Google Patents

Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus

Info

Publication number
GR3024480T3
GR3024480T3 GR970402119T GR970402119T GR3024480T3 GR 3024480 T3 GR3024480 T3 GR 3024480T3 GR 970402119 T GR970402119 T GR 970402119T GR 970402119 T GR970402119 T GR 970402119T GR 3024480 T3 GR3024480 T3 GR 3024480T3
Authority
GR
Greece
Prior art keywords
virus
hepatitis
screening
polynucleotides useful
hcv
Prior art date
Application number
GR970402119T
Other languages
English (en)
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Amy J Weiner
Jang Han
Michael Steven Urdea
Bruce Duncan Irvine
Janice A Kolberg
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of GR3024480T3 publication Critical patent/GR3024480T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR970402119T 1990-08-10 1997-08-19 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus GR3024480T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56620990A 1990-08-10 1990-08-10
PCT/US1991/005728 WO1992002642A1 (en) 1990-08-10 1991-08-12 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus

Publications (1)

Publication Number Publication Date
GR3024480T3 true GR3024480T3 (en) 1997-11-28

Family

ID=24261960

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402119T GR3024480T3 (en) 1990-08-10 1997-08-19 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus

Country Status (19)

Country Link
EP (1) EP0543924B1 (el)
JP (1) JP2714255B2 (el)
KR (1) KR0163964B1 (el)
AT (1) ATE154646T1 (el)
AU (1) AU660940B2 (el)
BG (1) BG61615B1 (el)
CA (1) CA2089080C (el)
CZ (1) CZ282573B6 (el)
DE (1) DE69126617T2 (el)
DK (1) DK0543924T3 (el)
ES (1) ES2104720T4 (el)
FI (1) FI106214B (el)
GR (1) GR3024480T3 (el)
HU (2) HUT69140A (el)
NO (1) NO308621B1 (el)
PL (1) PL169035B1 (el)
RO (1) RO109952B1 (el)
RU (1) RU2180354C2 (el)
WO (1) WO1992002642A1 (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571554A1 (en) * 1991-01-14 1993-12-01 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
ES2188583T3 (es) 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
DE69223562T2 (de) * 1991-08-27 1998-06-04 Hoffmann La Roche Verfahren und Reagenzien zum Nachweis von Hepatitis C
US5427909A (en) * 1991-09-09 1995-06-27 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
JP3688290B2 (ja) 1991-11-21 2005-08-24 コモン サーヴィシス エージェンシー C型肝炎ウイルス検査
AU4387193A (en) * 1992-05-29 1993-12-30 Abbott Laboratories Ligase chain reaction starting with rna sequences
JPH0670800A (ja) * 1992-08-26 1994-03-15 Imuno Japan:Kk Hcvゲノムの多様性検出方法、プライマー
JPH08506479A (ja) * 1992-09-10 1996-07-16 財団法人化学及血清療法研究所 C型肝炎ウイルス関連疾患の治療のための組成物および方法
DE69324678T2 (de) * 1992-11-27 1999-12-09 Naamloze Vennootschap Innogenetics S.A., Gent Verfahren zur typisierung von hcv-isolaten
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
JPH0775585A (ja) * 1993-06-14 1995-03-20 Immuno Japan:Kk C型肝炎ウイルス関連オリゴヌクレオチドならびにc型肝炎 ウイルス遺伝子型判定方法
JP5175417B2 (ja) 2000-08-17 2013-04-03 トリペップ アクチ ボラゲット リバビリンを含むワクチンおよびその使用方法
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
EP1540011B1 (en) * 2002-07-26 2010-01-06 Abbott Laboratories Method of detecting and quantifying hepatitis c virus
ES2596753T3 (es) 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
EP2185195A2 (en) 2007-08-16 2010-05-19 Tripep Ab Immunogen platform
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
WO1990009457A2 (en) * 1989-02-14 1990-08-23 Biogen, Inc. Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
GEP20002164B (en) * 1989-05-18 2000-07-10 Novartis Vaccines & Diagnostic Oligomers, method for detecting of hcv sequence, kit for its detecting, method for production of the blood free from hcv
CA2044296A1 (en) * 1990-06-12 1991-12-13 Hiroaki Okamoto Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
EP0933426A1 (en) * 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
ES2100185T3 (es) * 1990-07-11 1997-06-16 Shionogi & Co Secuencia de adnc y deteccion del virus de la hepatitis c.

Also Published As

Publication number Publication date
PL169035B1 (pl) 1996-05-31
HU227499B1 (en) 2011-07-28
EP0543924A4 (en) 1993-07-21
FI930582A (fi) 1993-04-07
FI930582A0 (fi) 1993-02-10
HU9300323D0 (en) 1993-05-28
ES2104720T3 (es) 1997-10-16
NO930429L (no) 1993-04-05
DE69126617D1 (de) 1997-07-24
ATE154646T1 (de) 1997-07-15
ES2104720T4 (es) 1997-12-16
BG97435A (bg) 1994-03-24
EP0543924A1 (en) 1993-06-02
JP2714255B2 (ja) 1998-02-16
CA2089080A1 (en) 1992-02-11
WO1992002642A1 (en) 1992-02-20
HUT69140A (en) 1995-08-28
NO930429D0 (no) 1993-02-08
EP0543924B1 (en) 1997-06-18
CZ282573B6 (cs) 1997-08-13
AU8509991A (en) 1992-03-02
KR0163964B1 (ko) 1998-11-16
CA2089080C (en) 2007-04-03
FI106214B (fi) 2000-12-15
CZ16793A3 (en) 1993-05-12
DE69126617T2 (de) 1997-10-02
BG61615B1 (bg) 1998-01-30
AU660940B2 (en) 1995-07-13
RU2180354C2 (ru) 2002-03-10
DK0543924T3 (da) 1997-09-08
JPH06503707A (ja) 1994-04-28
NO308621B1 (no) 2000-10-02
RO109952B1 (ro) 1995-07-28

Similar Documents

Publication Publication Date Title
HU904754D0 (en) Nanbv diagnostics and polynucleotides for detecting the hepatitis c virus
GR3024480T3 (en) Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
DE69334357D1 (de) Nachweis und Typisierung das Hepatitis C Virus (HCV) mittels 5'UTR und NS5 Nukleinsäuresequenzen
RU93004904A (ru) Способ обнаружения вируса гепатита с, набор, способ получения крови, реагент
HUT53148A (en) Process for producing vaccines against contamination by non-a, non-b hepatitis virus and diagnostics suitable for detecting contamination
CA2108466A1 (en) Hcv genomic sequences for diagnostics and therapeutics
HK1009980A1 (en) Method for selective inactivation of viral replication
HK1034094A1 (en) Hepatitis c virus cell culture system
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
WO1994025601A3 (en) New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
AU2001272257A1 (en) Hcv mosaic antigen composition
EP0460056A4 (en) Non-a, non-b hepatitis hepatocyte cell culture
EP0416725A3 (en) Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
GB9912432D0 (en) Novel gbv sequence
JPS53109564A (en) Vacuum forming of stepped article